ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO was delisted on the 27th of March, 2020.
3 hedge funds and large institutions have $934K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
50% less funds holding
Funds holding: 6 → 3 (-3)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
79% less capital invested
Capital invested by funds: $4.36M → $934K (-$3.43M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$346K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$1.78M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$289K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$21K |
| 4 |
VF
Virtu Financial
New York
|
-$754 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $563K | -$754 | -16 | -0.1% |
|
|
2
Jane Street
New York
| $352K | +$346K | +7,340 | New |
|
|
CG
3
Cutler Group
San Francisco,
California
| $19K | – | – | – |
|
|
EDRH
4
Edmond de Rothschild Holding
Chambesy,
Switzerland
| – | -$1.78M | -42,233 | Closed |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$289K | -6,133 | Closed |
|
|
IA
6
IFP Advisors
Tampa,
Florida
| – | -$21K | -500 | Closed |
|
ZBIO Hedge Fund Activity: Q4 2016 in Review
3 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) for Q4 2016, worth a combined $934K — down 79% from $4.36M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ZBIO and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Jane Street, opening a new position worth an estimated $346K. The largest seller was Edmond de Rothschild Holding, exiting entirely with an estimated $1.78M sold.
- 3 institutional investors held ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) as of Q4 2016, down from 6 in Q3 2016.
- Funds reported $934K of ProShares UltraPro Short NASDAQ Biotechnology stock for Q4 2016, down 79% quarter-over-quarter.
- 1 fund opened new ProShares UltraPro Short NASDAQ Biotechnology positions in Q4 2016 and 3 closed out, a net change of -2 holders.
- The largest ProShares UltraPro Short NASDAQ Biotechnology buyer in Q4 2016 was Jane Street, an estimated $346K added.
- The largest ProShares UltraPro Short NASDAQ Biotechnology seller in Q4 2016 was Edmond de Rothschild Holding, an estimated $1.78M sold.
Based on aggregated 13F filings for Q4 2016.